文献速递眼整形与眼眶

眼眶脂肪减压术治疗Graves眼病长期结局

Long-term outcomes of orbital fat decompression in Graves' orbitopathy.
PubMed 文献 · Br J Ophthalmol · 2017-04-27

回顾性分析2003–2014年845例(1604眼)对称或不对称性眼球突出患者接受眼眶脂肪减压术,随访37.9±24.4个月,85.1%眼达完全成功,眼球突出回退4.1±1.3 mm且在5–10年随访中维持稳定,生活质量显著提高。

要点

  • 随访37.9±24.4个月,完全成功1365眼(85.1%),部分成功219眼(13.7%),失败20眼(1.2%)。
  • 眼球突出总回退量4.1±1.3 mm,在中长期(5–10年)随访中保持一致。
  • 新发复视发生率3.3%,二次减压发生率0.6%,均保持低水平。

核心结论

  • 眼眶脂肪减压术矫正毁容性眼球突出具有长期疗效,并发症率低且无需二次减压手术,并与生活质量显著改善相关。

研究设计与样本

  • 回顾性研究,纳入2003年至2014年接受眼眶脂肪减压术的845例患者共1604眼,其中对称性眼球突出1518眼、不对称性86眼。

主要发现

  • 随访37.9±24.4个月后,1365眼(85.1%)完全成功,219眼(13.7%)部分成功,20眼(1.2%)失败。
  • 新发复视发生率为3.3%,二次减压发生率为0.6%。
  • 眼球突出总回退量为4.1±1.3 mm,在中期和长期(5–10年)随访中保持一致。
  • 眼眶脂肪去除量(4.5±1.1 mL)对长期Hertel值变化起重要作用。
  • Graves眼病患者接受眼眶脂肪减压术后整体生活质量显著提高。

关键数值与推荐

  • 完全成功定义为眼球突出回退且无复发、复视改善或无复视。
  • 部分成功定义为眼球突出回退且无复发,但复视持续或新发。
  • 失败定义为眼球突出复发,不论复视情况如何。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the long-term clinical efficacy of orbital fat decompression in treating proptosis in Graves' ophthalmopathy (GO). METHODS: Retrospective review of 1604 eyes of 845 patients with symmetric (1518 eyes) and asymmetric (86 eyes) proptosis who received orbital fat decompression between 2003 and 2014. Changes in Hertel values were evaluated at baseline, 6 months postoperatively and yearly thereafter. Recurrence of proptosis, diplopia and other complications that required additional surgeries were documented and analysed. The surgical outcome was defined as complete success if there was proptosis reduction with no recurrence and improved or no diplopia. Partial success was considered if there was proptosis reduction without recurrence yet persistent or new-onset diplopia. Failure was considered if there was recurrence of proptosis regardless of diplopia. The patient's quality of life was also evaluated as a long-term outcome. RESULTS: After follow-up for 37.9±24.4 months, 1365 eyes (85.1%) achieved complete success, 219 eyes (13.7%) achieved partial success and 20 eyes (1.2%) had failure. Newly onset diplopia and secondary decompression occurrence rate remained low at 3.3% and 0.6%, respectively. The total proptosis reduction was 4.1±1.3 mm, which was consistent all through the intermediate and long-term (5-10 years) follow-up. The amount of orbital fat removal (4.5±1.1 mL) played a significant role in the long-term Hertel change. Importantly, the overall quality of life increased significantly for GO patients after undergoing orbital fat decompression. CONCLUSIONS: Orbital fat decompression has a long-term efficacy in correcting disfiguring proptosis with a low complication rate and without the need of secondary decompression procedures. This was also associated with a significant improvement in quality of life.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Cheng AM, Wei YH, Tighe S, et al. Long-term outcomes of orbital fat decompression in Graves' orbitopathy. Br J Ophthalmol. 2017. PMID: 28450378. doi:10.1136/bjophthalmol-2016-309888

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。